These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 5067494

  • 1. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE, Folts JD, Afonso S, Rowe GG.
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract] [Full Text] [Related]

  • 2. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE, Folts JD, Afonso S, Rowe GG.
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract] [Full Text] [Related]

  • 3. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD.
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
    Katano Y, Takeda K, Otorii T, Horii D, Imai S.
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG, Terry W, Stenlund RR, Thomsen JH, Querimit AS.
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH, Brock N.
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
    Kraupp O, Grossmann W, Stühlinger W, Raberger G.
    Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
    [No Abstract] [Full Text] [Related]

  • 15. Cardiohemodynamic effects of BAY a 1040 in the dog.
    Hashimoto K, Taira N, Chiba S, Hashimoto K, Endo M.
    Arzneimittelforschung; 1972 Jan; 22(1):15-21. PubMed ID: 5066992
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs].
    Raberger G, Weissel M, Kraupp O.
    Arzneimittelforschung; 1973 Jun; 23(6):764-8. PubMed ID: 4740758
    [No Abstract] [Full Text] [Related]

  • 18. [Screening of substances with coronary vasodilator action].
    Lenke D.
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract] [Full Text] [Related]

  • 19. Systemic and coronary hemodynamic effects of Abbott (40557) and its interaction with aminophylline.
    Afonso S, Henderson RR, Folts JD, Rowe GG.
    Basic Res Cardiol; 1975 May; 70(4):390-400. PubMed ID: 1191207
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.